POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER

This article discusses the virology of Epstein-Barr virus (EBV) and pr ovides an overview of the disease states associated with the virus, de scribes how the immunology of EBV infection provides for control in th e normal host, and reviews what is currently known about post-transpla nt lymphoproliferative disorder (PTLD), including evidence for EBV in the pathogenesis of PTLD, risk factors for its development, clinical p resentation, methods for diagnosis, pathology, treatment, and current and future preventive strategies.